Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on INT 1. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1176903C reveals a novel catalytic hydrogenation route for N-[(S)-1-carboxybutyl]-S-alanine ester, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN105061393B reveals a novel route for (S)-(-)-3-methylamino-1-(2-thienyl)-1-propanol, offering >99% purity and >80% yield for scalable duloxetine production.
Patent CN103073456B details a high-purity stereoselective synthesis for rivastigmine intermediates, offering significant cost reduction in API manufacturing and scalable production.
Novel one-step preparation of Rifloxacin intermediate. Solves long route and toxic oxidant issues. High yield, scalable, and environment-friendly.
Novel patent CN105085599A reveals efficient Exemestane intermediate route. Reduces steps improves scalability for pharmaceutical manufacturing supply chains. Enables cost reduction.
Advanced enzymatic and chemical separation process for high-purity escitalopram intermediates. Reduces manufacturing costs and improves supply chain reliability for global API producers.
Novel patent CN116655532A offers high-yield Roxadustat intermediate synthesis. Safe reagents, scalable process, cost reduction in pharma manufacturing.
Novel synthesis route for Tacalcitol side chain intermediates reduces cost and improves yield. Reliable supplier for high-purity pharmaceutical intermediates.
Novel acylation method for posaconazole intermediate offers high purity and scalable production for pharmaceutical supply chains.
Patent CN1331883C reveals an efficient synthesis of perindopril intermediates using natural amino acids, offering significant cost reduction and supply chain stability for pharmaceutical manufacturers.
Novel iodination-amination route for Larotrectinib intermediate. Enhances purity above 98.5 percent and scalability. Reliable supply chain partner for pharmaceutical manufacturing.
Novel chemo-enzymatic route for Eluxadoline intermediate. High yield, scalable, cost-effective pharmaceutical intermediates manufacturing for global supply chains.
Patent CN119552837B reveals high-efficiency enzymatic route for Brivaracetam intermediates, offering superior purity and scalable manufacturing solutions for global supply chains.
Novel non-enzymatic synthesis of niraparib intermediate via oxazolone route. High purity, scalable process offering significant cost reduction in API manufacturing.
Patent CN102093245B details a cost-effective Suzuki coupling route for Sitagliptin intermediates. This method enhances supply chain reliability and reduces dependency on expensive noble metal catalysts for pharmaceutical manufacturing.
Novel enzymatic route for Sitagliptin key intermediate reduces costs and eliminates heavy metals. Ideal for reliable pharmaceutical intermediate suppliers seeking scalable API manufacturing solutions.
Novel synthesis route for SGLT inhibitor intermediates ensures high purity and cost efficiency. Reliable supply chain partner for commercial scale pharmaceutical manufacturing.
Novel patent CN109206357A offers safer gliclazide intermediate synthesis reducing costs and enhancing supply chain reliability for pharmaceutical manufacturers.
Patent CN103304524A reveals a cost-effective route for Ramelteon intermediates, eliminating toxic reagents and improving yield for reliable pharmaceutical intermediate suppliers.
Patent CN1761658A details a novel solubility-based purification for 1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile, ensuring superior supply chain reliability.